G

GSK

Develops medicines, vaccines, and consumer health

Medical Director - Oncology Clinical Development, Lung & Head/Neck Cancers

Biology & BiotechConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • An MD or equivalent medical degree, with board certification or eligibility in oncology, haematology, or a related specialty.
  • Clinical experience in oncology and/or relevant therapeutic areas, with direct exposure to clinical research or drug development.
  • Demonstrated experience in clinical trial conduct, including medical monitoring, safety review, and clinical data interpretation.
  • Experience applying clinical judgement to support study design, patient safety, and real-time medical decision-making within a structured clinical development framework.
  • Experience operating effectively within cross-functional matrix teams in a pharmaceutical, biotechnology, or academic clinical trial environment.
  • Experience translating clinical data into clear insights for internal and external audiences.

Responsibilities

  • Serve as the physician within the clinical programme team, providing medical expertise across study design, conduct, safety oversight, and data interpretation.
  • Lead medical monitoring activities for clinical studies, ensuring patient safety, clinical integrity, and compliance with the protocol and regulatory requirements.
  • Interpret clinical and safety data from a physician perspective, generating insights that inform study-level and programme-level decisions led by the Clinical Development Lead (CDL).
  • Partner with the Senior Scientist and cross-functional teams to ensure medical considerations are integrated into study execution and delivery.
  • Contribute medical expertise to protocol development, ensuring clinical relevance, patient safety, and feasibility within the framework defined by the CDL.
  • Serve as a core member of the Clinical Matrix Team (CMT), providing the medical voice in study-level discussions and cross-functional decision-making.
  • Engage with investigators and Key External Experts (KEEs) to support study conduct, scientific exchange, and external representation of the programme.
  • Contribute to regulatory documents, Health Authority interactions, and scientific communications from a physician perspective.
  • Lead medical monitoring activities for assigned clinical studies, including real-time clinical decision-making on patient eligibility, protocol-related medical queries, and safety oversight.
  • Conduct and oversee medical review of clinical trial data, both directly and through oversight of delegated medical review activities.
  • Interpret and contextualise safety data in collaboration with pharmacovigilance, ensuring appropriate signal detection, escalation, and benefit–risk assessment at the study level.
  • Participate in safety review forums, including Safety Review Team (SRT) discussions, Independent Data Monitoring Committee (IDMC) data reviews, and internal governance as required.
  • Ensure medical monitoring activities are conducted in compliance with GCP, ICH guidelines, and applicable regulatory frameworks.
  • Provide medical input into protocol development, ensuring clinical relevance, patient safety, and operational feasibility within the clinical strategy defined by the CDL.
  • Apply clinical judgement to support protocol implementation, addressing medical questions that arise during study conduct and ensuring consistency with the study’s scientific objectives.
  • Partner with the Senior Scientist to ensure that medical considerations are fully integrated into study execution, data generation, and operational delivery.
  • Contribute to the development and review of key study documents, including the Informed Consent Form (ICF), protocol deviation management plan (PDMP), and study reference manual (SRM).
  • Provide medical input into clinical data generation activities, ensuring alignment with study objectives, patient safety considerations, and the Clinical Development Plan (CDP).
  • Interpret clinical data from a physician perspective, translating findings into insights on safety, efficacy, and patient impact that inform decision-making by the CDL.
  • Contribute to study-level and programme-level data interpretation, supporting the CDL’s assessment of benefit–risk and clinical positioning.
  • Contribute to the development of scientific communications, including study reports, clinical study summaries, publications, and congress materials.
  • Collaborate with investigators on the evaluation and development of abstracts, posters, and manuscripts derived from clinical programme data.
  • Maintain current knowledge of the asset’s biological mechanism, disease landscape, evolving treatment paradigms, and competitive environment to inform clinical interpretation.
  • Contribute medical expertise to regulatory documents and Health Authority interactions, including responses to clinical and safety queries.
  • Support preparation of materials for regulatory submissions, advisory boards, and external engagements, providing the physician perspective on clinical data and safety.
  • Engage with KEEs, investigators, and scientific collaborators to support study conduct, scientific exchange, and relationship development.
  • Represent the medical perspective at cross-departmental interactions, including Integrated Evidence Team (IET) and Medical Affairs strategy discussions, as delegated by the CDL.
  • Contribute to the clinical and technical diligence assessment of business development opportunities as requested.
  • Serve as a core member of the CMT, providing medical leadership within study execution.
  • Contribute medical expertise to disease area strategy, integrated evidence planning, and Medical Affairs discussions as appropriate.
  • Collaborate across functions, including Clinical Operations, Biostatistics, Regulatory, and Pharmacovigilance, to ensure alignment on study objectives, patient safety, and data quality.
  • Contribute to Oncology Clinical Development-wide initiatives and workstreams.

Desired Qualifications

  • Experience in pharmaceutical or biotechnology clinical development across Phase I–III lung and head/neck oncology studies.
  • Strong working knowledge of clinical development processes, including GCP, ICH guidelines, and global regulatory frameworks.
  • Prior experience contributing to regulatory interactions, such as IND submissions, scientific advice, and NDA/MAA filings.
  • Demonstrated experience engaging with KEEs, investigators, and scientific collaborators in oncology.
  • Track record of contributing to clinical publications, congress presentations, or scientific communications.
  • Deep understanding of oncology disease biology, evolving treatment paradigms, and the competitive landscape across solid tumours and/or haematological malignancies.
  • Experience in medical monitoring across multiple studies or programmes within a clinical development organisation.
  • Familiarity with emerging data and analytics approaches, such as real-world evidence and AI-enabled insights, to support clinical interpretation and decision-making.

About the Company

GSK

Develops medicines, vaccines, and consumer health

GSK is a global healthcare company focused on three main areas: Pharmaceuticals, Vaccines, and Consumer Healthcare. It develops medicines, vaccines, and consumer health products to improve health outcomes worldwide. Its products address diseases in respiratory, HIV, oncology, and immuno-inflammatory areas; vaccines for influenza, shingles, and COVID-19; and over-the-counter wellness products. The company relies on substantial R&D and strategic partnerships to bring new products to market and to address health needs. Revenues come from sales of medicines, vaccines, and consumer health items, often complemented by patient support programs and collaborations with governments and biotech partners.

Company size
10,001+
Company stage
IPO
Headquarters
London, United Kingdom
Founded
1891

Recently Posted Jobs

Explore more opportunities at GSK

See more jobs